Extract of pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3k/AKT signaling pathway

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Xu, Wenwen ^a   Huang, Jim Jun hui ^a,b   Cheung, Peter Chi Keung ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANTOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FUNGAL EXTRACT; PHOSPHATIDYLINOSITOL 3 KINASE; PLEUROTUS PULMONARIUS EXTRACT; PROTEIN KINASE B; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER RESISTANCE; CELL CYCLE ARREST; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; MALE; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PLEUROTUS; PLEUROTUS PULMONARIUS; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; ANIMAL; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; CELL STRAIN HEPG2; CHEMISTRY; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER TUMOR; METABOLISM; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

BASIDIOMYCOTA; MUS MUSCULUS; PLEUROTUS; PLEUROTUS PULMONARIUS;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; INJECTIONS, INTRAPERITONEAL; LIVER NEOPLASMS; MICE; MICE, NUDE; PHOSPHATIDYLINOSITOL 3-KINASES; PLEUROTUS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859043508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034406     Document Type: Article

References (72)

1. El-Serag HB, Mason AC, (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750.
2. Llovet JM, Beaugrand M, (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38: 136-149.
3. Llovet JM, Burroughs A, Bruix J, (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917.
4. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, et al. (2006) Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 24: 4293-4300.
5. Bader AG, Kang S, Zhao L, Vogt PK, (2005) Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921-929.
6. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB, (2005) Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004.
7. Jia G, Mitra AK, Gangahar DM, Agrawal DK, (2010) Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein. Exp Mol Pathol 89: 20-26.
8. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, et al. (2004) Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24: 294-300.
9. Li H, Wu WK, Li ZJ, Chan KM, Wong CC, et al. (2010) 2,3′,4,4′,5′-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice. Br J Pharmacol 160: 1352-1361.
10. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, et al. (2009) Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev 18: 13-25.
11. Maria R, Carmela S, Idolo T, Gian LR, (2010) Phytochemicals in Cancer Prevention and Therapy: Truth or Dare? Toxins 2: 517-551.
12. Hassan FRH, Ghada MM, Abou Hussein SD, (2010) Cultivation of the king oyster mushroom (Plerrotus eryngii) in Egypt. Aust J Basic Appl Sci 4: 99-105.
13. Wasser SP, (2011) Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 89: 1323-1332.
14. Ooi VE, Liu F, (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem 7: 715-729.
15. Lee JS, Hong EK, (2011) Agaricus blazei Murill enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells by NFκB-mediated increase of intracellular doxorubicin accumulation. Int J Oncol 38: 401-408.
16. Mizuno M, Minato K, Ito H, Kawade M, Terai H, et al. (1999) Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem Mol Biol Int 47: 707-714.
17. Song KS, Li G, Kim JS, Jing K, Kim TD, et al. (2011) Protein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/β-catenin in SW480 human colon cancer cells. BMC Cancer 11: 307.
18. Tsuji T, Du W, Nishioka T, Chen L, Yamamoto D, Chen CY, (2010) Phellinus linteus extract sensitizes advanced prostate cancer cells to apoptosis in athymic nude mice. PLoS One 5: e9885.
19. Sliva D, Jedinak A, Kawasaki J, Harvey K, Slivova V, (2008) Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356.
20. Weng CJ, Yen GC, (2010) The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metasis 27: 361-369.
21. Iris L, Dana L, Irena P, Yoram T, Yitzhak H, et al. (2010) Chemical characterization, anti-proliferative and anti-adhesive properties of polysaccharides extracted from Pleurotus pulmonarius mycelium and fruiting bodies. Appl Microbiol Biotechnol 85: 1977-1990.
22. Gu YH, Sivam G, (2006) Cytotoxic effect of oyster mushroom Pleurotus ostreatus on human androgen-independent prostate cancer PC-3 cells. J Med Food 9: 196-204.
23. Chen JN, Wang YT, Wu JS, (2009) A glycoprotein extracted from golden oyster mushroom. Pleurotus citrinopileatus exhibiting growth inhibitory effect against U937 leukemia cells. J Agric Food Chem 57: 6706-6711.
24. Zhang M, Zhu L, Cui SW, Wang Q, Zhou T, et al. (2011) Fractionation, partial characterization and bioactivity of water-soluble polysaccharides and polysaccharide-protein complexes from Pleurotus geesteranus. Int J Biol Macromol 48: 5-12.
25. Cheung PCK, Lai TC, (2011) Effect of mushroom antioxidants on tumor angiogenesis. Abstract of Personalized Cancer Medicine 2011 Singapore Genome Institute of Singapore.
26. Basnet P, Skalko-Basnet N, (2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16: 4567-4598.
27. Shukla Y, Singh R, (2011) Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 1215: 1-8.
28. Khan N, Mukhtar H, (2007) Tea polyphenols for health promotion. Life Sci 81: 519-533.
29. Shimabukuro Y, Terashima H, Takedachi M, Maeda K, Nakamura T, et al. (2011) Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction. J Cell Physiol 226: 809-821.
30. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, et al. (2004) Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24: 294-300.
31. West KA, Castillo SS, Dennis PA, (2002) Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5: 234-248.
32. Khan HA, Alhomida AS, (2011) A review of the logistic role of l-carnitine in the management of radiation toxicity and radiotherapy side effects. J Appl Toxicol (in press).
33. Sánchez-González PD, López-Hernández FJ, López-Novoa JM, Morales AI, (2011) An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Crit Rev Toxicol (in press).
34. Fulda S, Debatin KM, (2004) Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23: 6702-6711.
35. Shankar S, Ganapathy S, Srivastava RK, (2007) Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci 12: 4881-4899.
36. Wasonga CG, Okoth SA, Mukuria JC, Omwandho CO, (2008) Mushroom polysaccharide extracts delay progression of carcinogenesis in mice. 7: 147-52.
37. Schrenk D, (2009) Dietary fiber, low-molecular-weight food constituents and colo-rectal inflammation in animal models - a review. Mol Nutr Food Res 53: 1281-1288.
38. Rexer BN, Ham AJ, Rinehart C, Hill S, de Matos Granja-Ingram N, et al. (2011) Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene 30: 4163-4174.
39. Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB, (2011) Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215: 150-160.
40. Steelman LS, Navolanic P, Chappell WH, Abrams SL, Wong EW, et al. (2011) Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Cell Cycle 10: 3003-3015.
41. McCubrey JA, Steelman LS, Kempf CR, Chappell WH, Abrams SL, et al. (2011) Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways. Cell Physiol 226: 2762-2781.
42. Chen KF, Chen HL, Tai WT, Feng WC, Hsu CH, et al. (2011) Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharmacol Exp Ther 337: 155-161.
43. She QB, Solit D, Basso A, Moasser MM, (2003) Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3′-kinase/Akt pathway signaling. Clin Cancer Res 9: 4340-4346.
44. Nalla AK, Estes N, Patel J, Rao JS, (2011) N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells. Exp Cell Res 317: 2512-2521.
45. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 67: 3106-3116.
46. Satelli A, Li S, (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-46.
47. Mendez MG, Kojima S, Goldman RD, (2010) Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J 24: 1838-1851.
48. Singh A, Settleman J, (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
49. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, et al. (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mamm Gland Biol Neopla 15: 261-273.
50. Thiery JP, Acloque H, Huang RY, Nieto MA, (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
51. de Herreros AG, Peiró S, Nassour M, Savagner P, (2010) Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mamm Gland Biol Neopla 15: 135-147.
52. West KA, Castillo SS, Dennis PA, (2002) Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5: 234-248.
53. Michl P, Downward J, (2005) Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers. Z Gastroenterol 43: 1133-1139.
54. Liu P, Cheng H, Roberts TM, Zhao JJ, (2009) Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8: 627-644.
55. Jin CY, Kim GY, Choi YH, (2008) Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 Cells. J Microbiol Biotechnol 18: 1997-2003.
56. Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H, (2004) Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem 91: 232-242.
57. Zhou Q, Lui VW, Yeo W, (2011) Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Future Oncol 7: 1149-67.
58. Zucman-Rossi J, (2010) Molecular classification of hepatocellular carcinoma. Dig Liver Dis 42: S235-41.
59. Villanueva A, Llovet JM, (2011) Targeted therapies for hepatocellular carcinoma. Gastroenterology 140: 1410-26.
60. Halper J, (2010) Growth factors as active participants in carcinogenesis: A perspective. Vet Pathol 47: 77-97.
61. Aharinejad S, Sioud M, Lucas T, Abraham D, (2009) Targeting stromal-cancer cell interactions with siRNAs. Methods Mol Biol 487: 243-66.
62. Mahadevan D, Von Hoff DD, (2007) Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 6: 1186-1197.
63. Azam F, Mehta S, Harris AL, (2010) Mechanisms of resistance to antiangiogenesis therapy. Eur J Cancer 46: 1323-1332.
64. Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VC, et al. (2007) Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. Recent Pat Antican Drug Discov 2: 59-71.
65. Sliva D, Jedinak A, Kawasaki J, Harvey K, Slivova V, (2008) Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-56.
66. Song KS, Li G, Kim JS, Jing K, Kim TD, et al. (2011) Protein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/β-catenin in SW480 human colon cancer cells. BMC Cancer 11: 307.
67. Zhang J, Shan Y, Pan X, He L, (2011) Recent advances in antiangiogenic agents with VEGFR as target. Mini Rev Med Chem (in press).
68. Pircher A, Medinger M, Drevs J, (2011) Liver cancer: Targeted future options. World J Hepatol 3: 38-44.
69. Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, et al. (2005) Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal Biochem 339: 69-72.
70. Hartree EF, (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem 48: 422-427.
71. Zhao JY, Cheung PC, (2011) Fermentation of β-glucans derived from different sources by bifidobacteria: evaluation of their bifidogenic effect. J Agric Food Chem 59: 5986-5992.
72. Li B, Li YY, Tsao SW, Cheung AL, (2009) Targeting NF-kB signaling pathway suppresses tumor growth, angiogenesis, and metastasis of human esophageal cancer. Mol Cancer Ther 8: 2635-2644.